Jonathan Epstein, MD, Dean, Perelman School of Medicine and Executive Vice President of the University of Pennsylvania for the Health System, and Jim Wilson, MD, PhD, Emeritus Professor of Medicine at Penn Medicine and co-founder of GEMMABio Biotherapeutics and Franklin Biolabs, discussed the impact of federal funding cuts and emphasized the need for strong government partnerships to advance and deliver genetic medicines. Learn more here.